Rheumatic Diseases and Biosimilars: Evidence about Switch from Originators to Biosimilars in the Real Life
Biosimilars are broadly available for the treatment of several diseases including inflammatory arthritis. Thanks to biosimilars it has been possible to treat a greater number of rheumatic patients who previously were undertreated due to the high cost of originators, in several countries. There are a...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2021
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/78727 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|